Larry Ellison, AI and Oracle

AI can develop personalised cancer vaccine in 48 hours: Oracle's Larry Ellison
Oracle chairman Larry Ellison has announced that AI will soon develop customised mRNA vaccine against cancer for every individual within 48 hours.
Moderna spikes as Oracle’s Larry Ellison touts AI-driven mRNA vaccines
Chairman Larry Ellison highlighted the AI's potential in the development of mRNA-based cancer vaccines. Read more here.
Stargate AI project could help create cancer mRNA vaccine, Oracle CEO Larry Ellison says
We're learning more about a massive artificial intelligence infrastructure bill announced Tuesday by President Donald Trump.
Oracle's Larry Ellison Says Cancer Vaccine Tailored In 48 Hours Could Soon Be A Reality As Trump Announces $500 Billion AI Investment
Larry Ellison unveiled plans for an AI-driven cancer vaccine system that could deliver personalized treatments within 48 hours.
Oracle’s Larry Ellison on AI cancer detection game-changer
Oracle founder Larry Ellison detailed how “Project Stargate” will enable early cancer detection and the overall treatment of cancers in what is being considered a breakthrough healthcare technology.
Moderna Surges After Larry Ellison Calls Out The Potential Of AI In Cancer Vaccines
Moderna stock surged Wednesday after Oracle Chairman Larry Ellison praised the potential of AI in developing medicines.

Moderna, mRNA

Trump announces $500B AI infrastructure project — with biz titans saying it can cure cancer
WASHINGTON — President Trump unveiled a $500 billion artificial intelligence infrastructure project Tuesday at the White ...
What is Stargate, Trump's ambitious AI infrastructure venture?
The $500 billion Stargate project is projected to create hundreds of thousands of jobs. Here's what's known so far.
As avian influenza A(H5N1) concerns continue, mRNA vaccines offer great potential
With cases of avian influenza A(H5N1) continuing to rise among cattle and humans in the US, scientists and government health ...
Why Moderna (MRNA) Stock Is Advancing Today
RNA vaccine developer Moderna (MRNA) is climbing nearly 5% in early trading today after it was awarded about $590 million by ...